• レポートコード:TMR2006018 • 出版社/出版日:Transparency Market Research / 2020年3月 • レポート形態:英文、PDF、199ページ • 納品方法:Eメール • 産業分類:医薬品 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、リポソームドラッグデリバリーの世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、製品別(リポソームドキソルビシン、リポソームパクリタキセル、リポソームアンフォテリシン、その他)分析、技術別分析、用途別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などを総合的に調査・分析して掲載しております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・キーインサイト ・リポソームドラッグデリバリーの世界市場規模:製品別(リポソームドキソルビシン、リポソームパクリタキセル、リポソームアンフォテリシン、その他) ・リポソームドラッグデリバリーの世界市場規模:技術別 ・リポソームドラッグデリバリーの世界市場規模:用途別 ・リポソームドラッグデリバリーの世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ) ・競争状況 |
Liposome Drug Delivery Market – Scope of the Report
TMR’s report on the global liposome drug delivery market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period from 2019 to 2027. The report provides the overall revenue of the global liposome drug delivery market from 2017 to 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compounded annual growth rate (CAGR) for the global liposome drug delivery market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global liposome drug delivery market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global liposome drug delivery market.
The report includes an elaborate executive summary along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global liposome drug delivery market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global liposome drug delivery market. The next section of the report highlights the USPs, which include pipeline analysis, drugs in the clinical usage, and regulatory scenario assessment in the global liposome drug delivery market.
The report delves into the competitive landscape of the global liposome drug delivery market. Key players operating in the global liposome drug delivery market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global liposome drug delivery market report.
Key Questions Answered in Liposome Drug Delivery Market Report
What will be the sales revenue generated by liposome drug delivery across all regions during the forecast period?
What are the key trends in the global liposome drug delivery market?
What are major drivers, restraints, and opportunities in the global liposome drug delivery market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which application segment will generate the maximum revenue by 2027 and which product segment will expand at the fastest CAGR during the forecast period?
Liposome Drug Delivery Market – Research Objectives and Research Approach
The comprehensive report on the global liposome drug delivery market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global liposome drug delivery market. It is followed by market introduction, market dynamics, and an overview of the global liposome drug delivery market, which includes TMR’s analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global liposome drug delivery market report highlights the USPs, which include regulatory scenarios for liposome drug delivery globally, pipeline analysis, and developments in the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key players in the global liposome drug delivery market has been mapped to ascertain the size of the global liposome drug delivery market in terms of value. The forecast presented here assesses the total revenue generated in the global liposome drug delivery market. In order to provide an accurate forecast, we initiated by sizing up the current liposome drug delivery market with the help of the parent market.
The report analyzes the global liposome drug delivery market in terms of product, technology, application, and region. Key segments under each criteria have been studied at length and the market share of each of these by the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global liposome drug delivery market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms
3. Research Methodology
4. Executive Summary: Global Liposome Drug Delivery Market
5. Market Overview
5.1. Definition
5.2. Market Indicators
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunities
5.4. Global Liposome Drug Delivery Market Revenue (US$ Mn) Forecast 2017–2027
5.5. Global Liposome Drug Delivery Market Outlook
6. Key Insights
6.1. Pipeline Analysis
6.2. Clinically Marketed Liposome Drugs
6.3. Regulatory Scenario Assessment
7. Global Liposome Drug Delivery Market Analysis and Forecast, by Product
7.1. Introduction
7.2. Global Liposome Drug Delivery Market Value Share Analysis, by Product
7.3. Global Liposome Drug Delivery Market Value Forecast, by Product, 2017–2027
7.3.1. Liposomal Doxorubicin
7.3.2. Liposomal Paclitaxel
7.3.3. Liposomal Amphotericin B
7.3.4. Others
7.4. Global Liposome Drug Delivery Market Attractiveness Analysis, by Product
8. Global Liposome Drug Delivery Market Analysis and Forecast, by Technology
8.1. Introduction
8.2. Global Liposome Drug Delivery Market Value Share Analysis, by Technology
8.3. Global Liposome Drug Delivery Market Value Forecast, by Technology, 2017–2027
8.3.1. Stealth Liposome Technology
8.3.2. Non-PEGylated Liposome Technology
8.3.3. DepoFoam Liposome Technology
8.4. Global Liposome Drug Delivery Market Attractiveness Analysis, by Technology
9. Global Liposome Drug Delivery Market Analysis and Forecast, by Application
9.1. Introduction
9.2. Global Liposome Drug Delivery Market Value Share Analysis, by Application
9.3. Global Liposome Drug Delivery Market Value Forecast, by Technology, 2017–2027
9.3.1. Fungal Diseases
9.3.2. Pain Management
9.3.3. Cancer Therapy
9.3.4. Viral Vaccines
9.3.5. Photodynamic Therapy
9.4. Global Liposome Drug Delivery Market Attractiveness Analysis, by Technology
10. Global Liposome Drug Delivery Market Analysis and Forecast, by Region
10.1. Regional Outlook
10.2. Introduction
10.3. Global Liposome Drug Delivery Market Value Forecast, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
10.4. Global Liposome Drug Delivery Market Attractiveness Analysis, by Region
11. North America Liposome Drug Delivery Market Analysis and Forecast
11.1. Key Findings
11.2. North America Liposome Drug Delivery Market Value Forecast, by Product, 2017–2027
11.2.1. Liposomal Doxorubicin
11.2.2. Liposomal Paclitaxel
11.2.3. Liposomal Amphotericin B
11.2.4. Others
11.3. North America Liposome Drug Delivery Market Value Forecast, by Technology, 2017–2027
11.3.1. Stealth Liposome Technology
11.3.2. Non-PEGylated Liposome Technology
11.3.3. DepoFoam Liposome Technology
11.4. North America Liposome Drug Delivery Market Value Forecast, by Application, 2017–2027
11.4.1. Fungal Diseases
11.4.2. Pain Management
11.4.3. Cancer Therapy
11.4.4. Viral Vaccines
11.4.5. Photodynamic Therapy
11.5. North America Liposome Drug Delivery Market Value Forecast, by Country, 2017–2027
11.5.1. U.S.
11.5.2. Canada
11.6. North America Liposome Drug Delivery Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Technology
11.6.3. By Application
11.6.4. By Country
12. Europe Liposome Drug Delivery Market Analysis and Forecast
12.1. Key Findings
12.2. Europe Liposome Drug Delivery Market Value Forecast, by Product, 2017–2027
12.2.1. Liposomal Doxorubicin
12.2.2. Liposomal Paclitaxel
12.2.3. Liposomal Amphotericin B
12.2.4. Others
12.3. Europe Liposome Drug Delivery Market Value Forecast, by Technology, 2017–2027
12.3.1. Stealth Liposome Technology
12.3.2. Non-PEGylated Liposome Technology
12.3.3. DepoFoam Liposome Technology
12.4. Europe Liposome Drug Delivery Market Value Forecast, by Application, 2017–2027
12.4.1. Fungal Diseases
12.4.2. Pain Management
12.4.3. Cancer Therapy
12.4.4. Viral Vaccines
12.4.5. Photodynamic Therapy
12.5. Europe Liposome Drug Delivery Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. U.K.
12.5.2. Germany
12.5.3. France
12.5.4. Italy
12.5.5. Spain
12.5.6. Rest of Europe
12.6. Europe Liposome Drug Delivery Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Technology
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Asia Pacific Liposome Drug Delivery Market Analysis and Forecast
13.1. Key Findings
13.2. Asia Pacific Liposome Drug Delivery Market Value Forecast, by Product, 2017–2027
13.2.1. Liposomal Doxorubicin
13.2.2. Liposomal Paclitaxel
13.2.3. Liposomal Amphotericin B
13.2.4. Others
13.3. Asia Pacific Liposome Drug Delivery Market Value Forecast, by Technology, 2017–2027
13.3.1. Stealth Liposome Technology
13.3.2. Non-PEGylated Liposome Technology
13.3.3. DepoFoam Liposome Technology
13.4. Asia Pacific Liposome Drug Delivery Market Value Forecast, by Application, 2017–2027
13.4.1. Fungal Diseases
13.4.2. Pain Management
13.4.3. Cancer Therapy
13.4.4. Viral Vaccines
13.4.5. Photodynamic Therapy
13.5. Asia Pacific Liposome Drug Delivery Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. China
13.5.2. India
13.5.3. Japan
13.5.4. Australia & New Zealand
13.5.5. Rest of Asia Pacific
13.6. Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Technology
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Latin America Liposome Drug Delivery Market Analysis and Forecast
14.1. Key Findings
14.2. Latin America Liposome Drug Delivery Market Value Forecast, by Product, 2017–2027
14.2.1. Liposomal Doxorubicin
14.2.2. Liposomal Paclitaxel
14.2.3. Liposomal Amphotericin B
14.2.4. Others
14.3. Latin America Liposome Drug Delivery Market Value Forecast, by Technology, 2017–2027
14.3.1. Stealth Liposome Technology
14.3.2. Non-PEGylated Liposome Technology
14.3.3. DepoFoam Liposome Technology
14.4. Latin America Liposome Drug Delivery Market Value Forecast, by Application, 2017–2027
14.4.1. Fungal Diseases
14.4.2. Pain Management
14.4.3. Cancer Therapy
14.4.4. Viral Vaccines
14.4.5. Photodynamic Therapy
14.5. Latin America Liposome Drug Delivery Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America
14.6. Latin America Liposome Drug Delivery Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Technology
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Middle East & Africa Liposome Drug Delivery Market Analysis and Forecast
15.1. Key Findings
15.2. Middle East & Africa Liposome Drug Delivery Market Value Forecast, by Product, 2017–2027
15.2.1. Liposomal Doxorubicin
15.2.2. Liposomal Paclitaxel
15.2.3. Liposomal Amphotericin B
15.2.4. Others
15.3. Middle East & Africa Liposome Drug Delivery Market Value Forecast, by Technology, 2017–2027
15.3.1. Stealth Liposome Technology
15.3.2. Non-PEGylated Liposome Technology
15.3.3. DepoFoam Liposome Technology
15.4. Middle East & Africa Liposome Drug Delivery Market Value Forecast, by Application, 2017–2027
15.4.1. Fungal Diseases
15.4.2. Pain Management
15.4.3. Cancer Therapy
15.4.4. Viral Vaccines
15.4.5. Photodynamic Therapy
15.5. Middle East & Africa Liposome Drug Delivery Market Value Forecast, by Country/Sub-region, 2017–2027
15.5.1. GCC Countries
15.5.2. South Africa
15.5.3. Rest of Middle East & Africa
15.6. Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis
15.6.1. By Product
15.6.2. By Technology
15.6.3. By Application
15.6.4. By Country/Sub-region
16. Competition Landscape
16.1. Company Profiles
16.1.1. Spectrum Pharmaceuticals, Inc.
16.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.1.2. Financial Overview
16.1.1.3. Product Portfolio
16.1.1.4. Strategic Overview
16.1.1.5. SWOT Analysis
16.1.2. Astellas Pharma Inc.
16.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.2.2. Financial Overview
16.1.2.3. Product Portfolio
16.1.2.4. Strategic Overview
16.1.2.5. SWOT Analysis
16.1.3. Gilead Sciences, Inc.
16.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.3.2. Financial Overview
16.1.3.3. Product Portfolio
16.1.3.4. Strategic Overview
16.1.3.5. SWOT Analysis
16.1.4. Celsion Corporation
16.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.4.2. Financial Overview
16.1.4.3. Product Portfolio
16.1.4.4. Strategic Overview
16.1.4.5. SWOT Analysis
16.1.5. Ipsen Pharma
16.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.5.2. Financial Overview
16.1.5.3. Product Portfolio
16.1.5.4. Strategic Overview
16.1.5.5. SWOT Analysis
16.1.6. Pacira BioSciences, Inc.
16.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.6.2. Financial Overview
16.1.6.3. Product Portfolio
16.1.6.4. Strategic Overview
16.1.6.5. SWOT Analysis
16.1.7. Luye Pharma Group
16.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.7.2. Financial Overview
16.1.7.3. Product Portfolio
16.1.7.4. Strategic Overview
16.1.7.5. SWOT Analysis
16.1.8. Novartis AG
16.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.8.2. Financial Overview
16.1.8.3. Product Portfolio
16.1.8.4. Strategic Overview
16.1.8.5. SWOT Analysis
16.1.9. Takeda Pharmaceutical Company Limited
16.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.9.2. Financial Overview
16.1.9.3. Product Portfolio
16.1.9.4. Strategic Overview
16.1.9.5. SWOT Analysis
16.1.10. Johnson & Johnson
16.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.10.2. Financial Overview
16.1.10.3. Product Portfolio
16.1.10.4. Strategic Overview
16.1.10.5. SWOT Analysis
List of TablesTable 01: Pipeline Analysis - Liposome Drug Delivery Systems
Table 02: Clinically Marketed Liposome Drugs
Table 03: Regulations - Principle difference between U.S., EU, and India
Table 04: Regulatory Scenario Assessment - Administrative Requirements
Table 05: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 06: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 07: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 08: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 09: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 11: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 12: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 13: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 16: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 17: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 19: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 20: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 21: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 23: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 24: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 25: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 27: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 28: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017–2027